Results 171 to 180 of about 9,669,605 (361)
Mineral resources in life cycle impact assessment—part I: a critical review of existing methods
T. Sonderegger +19 more
semanticscholar +1 more source
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
The life cycle of star clusters in a tidal field [PDF]
Mark Gieles +2 more
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Life Cycle Assessment and Life Cycle Costing of Supercapacitors: A Comprehensive Review and Assessment of Environmental and Economic Impacts. [PDF]
Bahmei F +6 more
europepmc +1 more source
Hepatitis B virus biology and life cycle.
Senko Tsukuda, Koichi Watashi
semanticscholar +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Thiamine Allocation and Deficiency Status Throughout the Life Cycle of Cod. [PDF]
Hauber MM +6 more
europepmc +1 more source

